Amgen Slashes the Price of a Promising Cholesterol Drug

By KATIE THOMAS
NYT
The drug maker cut the list price of the drug Repatha by 60 percent in an effort to increase sales, which have been meager.
Published date: October 25, 2018 at 11:33PM
The New York Times
New York Times article

In Medical Reporting, the Impact of Patients’ Stories

By GINA KOLATA
NYT
A highly unusual response to my article on insurance obstacles to obtaining powerful new cholesterol-lowering drugs came from the very top: the leaders of one of the two companies making the drugs.
Published date: October 9, 2018 at 01:02PM
The New York Times
New York Times article